The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real-world multicenter study

被引：3
|
作者：
Fei, Xiaochen [1 ]
Fan, Liancheng [1 ]
Chen, Wei [2 ,3 ]
Chen, Wei [2 ,3 ]
Gong, Yiming [1 ]
Du, Xinxing [1 ]
Wang, Yanqing [1 ]
Zhu, Yinjie [1 ]
Pan, Jiahua [1 ]
Wang, Fangqin [4 ]
Zhao, Wanbing [4 ]
Liu, Tongtong [4 ]
Yang, Yining [4 ]
Dong, Baijun [1 ]
Xue, Wei [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Urol, Shanghai 200127, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Urol, Wenzhou, Zhejiang, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Shanghai Med Coll, Dept Urol, Shanghai, Peoples R China
[4] GloriousMedTechnologyCo Ltd, Shanghai, Peoples R China
来源：
CLINICAL AND TRANSLATIONAL MEDICINE | 2021年 / 11卷 / 10期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1002/ctm2.527
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Real-world evidence on clinical value of germline alterations of cancer predisposition genes in Chinese epithelial ovarian cancer
    Li, L.
    Zhu, C.
    Shao, D.
    Wu, M.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 145 - 145
  • [2] A multicenter study assessing the prevalence of germline genetic alterations in Chinese gastric-cancer patients
    Zhang, Yin-Jie
    Yang, Yang
    Wei, Qing
    Xu, Ting
    Zhang, Xiao-Tian
    Gao, Jing
    Tan, Si-Yi
    Liu, Bao-Rui
    Zhang, Jing-Dong
    Chen, Xiao-Bing
    Wang, Zhao-Jie
    Qiu, Meng
    Wang, Xin
    Shen, Lin
    Wang, Xi-Cheng
    GASTROENTEROLOGY REPORT, 2021, 9 (04): : 339 - 349
  • [3] Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study
    Zheng, Hong
    Gao, Yunong
    Guo, Hongyan
    Li Li
    Li, Qingshui
    Cui, Heng
    Lin, An
    Sun, Lixin
    Hu, Yuanjing
    Kang, Shan
    Duan, Wei
    Pan, Lingya
    Wang, Shuzhen
    Yang, Yingjie
    Li, Yunxia
    Kong, Weimin
    Xiang, Yang
    Tian, Xiaofei
    Ling, Bin
    Ha, Chunfang
    Bai, Wenpei
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (09) : 1735 - 1742
  • [4] Brentuximab vedotin in treating Chinese patients with lymphoma: A multicenter, real-world study
    Zhang, Xudong
    Qiao, Honghan
    Chai, Xiaofei
    Gao, Xue
    Ma, Rongjun
    Li, Yufu
    Zhu, Zunmin
    Zhang, Mingzhi
    CANCER MEDICINE, 2023, 12 (24): : 21725 - 21734
  • [5] Real-world multicenter study of T-DXd treatment in Chinese patients with metastatic breast cancer
    Wang, Biyun
    Li, Yumeng
    Zhao, Yannan
    Sang, Die
    Yuan, Peng
    Zhao, Yanxia
    Lv, Zheng
    Xie, Ning
    Li, Nanling
    Li, Juanjuan
    Wang, Fang
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55
  • [6] IS KI67 PROGNOSTIC FOR AGGRESSIVE PROSTATE CANCER? A MULTICENTER REAL-WORLD STUDY
    Fantony, Joseph J.
    Howard, Lauren E.
    Csizmadi, Ilona
    Armstrong, Andrew J.
    Lark, Amy L.
    Galet, Colette
    Aronson, William J.
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E453 - E453
  • [7] Is Ki67 prognostic for aggressive prostate cancer? A multicenter real-world study
    Fantony, Joseph J.
    Howard, Lauren E.
    Csizmadi, Ilona
    Armstrong, Andrew J.
    Lark, Amy L.
    Galet, Colette
    Aronson, William J.
    Freedland, Stephen J.
    BIOMARKERS IN MEDICINE, 2018, 12 (07) : 727 - 736
  • [8] Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study
    Ose, Dominik J.
    Viskochil, Richard
    Holowatyj, Andreana N.
    Larson, Mikaela
    Wilson, Dalton
    Dunson, William A., Jr.
    Deshmukh, Vikrant G.
    Butcher, J. Ryan
    Taylor, Belinda R.
    Svoboda, Kim
    Leiser, Jennifer
    Tingey, Benjamin
    Haaland, Benjamin
    Wetter, David W.
    Fisher, Simon J.
    Hashibe, Mia
    Ulrich, Cornelia M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (06): : 709 - +
  • [9] Effectiveness and Safety of Belimumab in Chinese Lupus Patients: A Multicenter, Real-World Observational Study
    Sun, Fangfang
    Wu, Huaxiang
    Wang, Zitao
    Wu, Tong
    Wu, Xue
    Chen, Jie
    Zhang, Danting
    Bao, Chunde
    Shen, Nan
    Wu, Lijun
    Zhu, Jing
    Ye, Shuang
    BIOMEDICINES, 2023, 11 (03)
  • [10] MULTICENTER GERMLINE BRCA1/2 PREVALENCE STUDY IN CHINESE OVARIAN CANCER PATIENTS
    Wu, X.
    Wu, L.
    Kong, B.
    Liu, J.
    Yin, R.
    Wen, H.
    Li, N.
    Bu, H.
    Feng, Y.
    Li, Q.
    Lu, X.
    Wei, J.
    Liu, Y. Z.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 23 - 23
12345